Homepage
About Us
Company Introduction
Guangzhou Bio-island Novel Drug Clinical Research Co., LTD (GBNC) was established in May 2022. It is an innovative drug and device clinical trial service platform jointly established by Guangzhou International Bio-Island Group Co., Ltd. and Guangzhou Sino-Israel Phase II Bioindustry Investment Fund.
GBNC is a platform for the establishment of an organization specially established to promote the establishment of the Guangzhou China-Israel Cooperation Zone, which was proposed by the Guangzhou China-Israel Cooperation Zone International Clinical Research Expert Team to the Guangzhou Municipal Government and subsequently accepted by the Guangzhou CPPCC as a formal proposal. With the support and guidance of the government, GBNC integrates resources from multiple parties such as industry, academia, research, medicine, and government to promote resource matching, team matching, and model matching, and cooperates with the sponsor to carry out clinical research operation management, drug and device R&D and registration-related regulatory communication, and clinical trial subsidy or preferential policy application. It is a "one-stop" partner for drug and device companies.
Platform Purpose
Platform Concept
Introduce world-class clinical research experience and international innovative drug and medical device projects, establish a new drug research and development data sharing mechanism in Guangzhou, and become the basis for R&D project establishment and decision-making. Improve Guangzhou's new drug clinical research ecosystem, enhance the level and efficiency of Guangzhou's clinical research, and present Guangzhou's city card of biomedicine to international companies.
Platform Vision
Build a leading new drug industry cluster and a complete new drug innovation system.
Service
We are good at
Medical Research Information System
Integrated IIT management system tailored for hospitals and researchers
The Medical Research Information System is an integrated IIT research management platform designed specifically for medical institutions, covering the entire process from project establishment to result analysis. The system integrates AI technology to achieve intelligent data processing, supports multi-terminal remote data collection, and ensures data security through localized deployment and blockchain technology. The system uses an efficient computing architecture to ensure stable performance and can be customized according to hospital needs. With only 5% of the investment in the IST system, it provides researchers with professional and efficient research management tools to help promote the innovative development of medical research.
Client Cases
Consultant Team
Our team is dedicated to providing our clients with the highest quality service and solutions.
Contact Us
If you have additional questions or comments, please fill out the contact form to communicate with a member of our team.
Contact number
13418091418
Fiona@gbnccenter.com
Address
Area A, 2nd Floor, Building 1, Phase 3, Helix 3 Road, Guangzhou International Bio-Island, Huangpu District, Guangzhou